UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.4% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 301,454 shares of the healthcare conglomerate’s stock after purchasing an additional 7,005 shares during the quarter. UnitedHealth Group comprises approximately 1.7% of Gateway Investment Advisers LLC’s holdings, making the stock its 7th biggest position. Gateway Investment Advisers LLC’s holdings in UnitedHealth Group were worth $154,836,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. PFG Advisors increased its stake in shares of UnitedHealth Group by 3.0% during the second quarter. PFG Advisors now owns 7,559 shares of the healthcare conglomerate’s stock worth $3,882,000 after purchasing an additional 222 shares during the period. Mechanics Bank Trust Department grew its position in shares of UnitedHealth Group by 4.2% during the 2nd quarter. Mechanics Bank Trust Department now owns 7,421 shares of the healthcare conglomerate’s stock worth $3,811,000 after purchasing an additional 302 shares in the last quarter. Guardian Financial Partners LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $216,000. Stokes Capital Advisors LLC increased its stake in UnitedHealth Group by 1.8% during the 2nd quarter. Stokes Capital Advisors LLC now owns 15,107 shares of the healthcare conglomerate’s stock worth $7,760,000 after acquiring an additional 265 shares during the period. Finally, Castle Rock Wealth Management LLC lifted its position in shares of UnitedHealth Group by 2.1% during the 2nd quarter. Castle Rock Wealth Management LLC now owns 1,939 shares of the healthcare conglomerate’s stock valued at $997,000 after acquiring an additional 39 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $517.46 on Friday. The company has a market cap of $484.02 billion, a P/E ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average price of $530.11 and a two-hundred day moving average price of $512.45. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period in the prior year, the business earned $4.70 EPS. The company’s revenue for the quarter was up 12.6% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s payout ratio is currently 34.46%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares in the company, valued at approximately $40,415,496.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders have sold 139,051 shares of company stock valued at $74,450,958 over the last ninety days. 0.40% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. SVB Leerink upped their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Credit Suisse Group boosted their target price on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. UBS Group lifted their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, July 21st. Finally, Sanford C. Bernstein lowered shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price on the stock. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $586.40.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.